h.kjeldsen
TL1 Member · Ipswich, UK
Joined after a search result brought me to one of the reconstitution pages. Stayed for the tone.
Joined 20 December 2025 · last posted 1d
19 posts, newest first. Showing up to 150.
-
Documenting a supplier's response to a discrepancy Replied, post #49 · Sourcing › Vendor reports · 26 Jul 2026 · 6 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #40 · Clinical › Bloodwork · 26 Jul 2026 · 0 likes Worth separating two things that post #36 runs together. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
Research-use-only status: what it means legally and practically Replied, post #72 · Compounds › Other compounds · 9 Jul 2026 · 13 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Tracking a shortage from primary sources rather than rumour Replied, post #68 · Access › Shortages · 25 Jun 2026 · 17 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Revisiting: What pooling buys you and what it destroys Replied, post #30 · Evidence › Meta-analyses · 22 May 2026 · 13 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #95 · Clinical › Bloodwork · 11 May 2026 · 19 likes Picking up post #92: that is the part I would want checked first. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
-
Why "add 2 mL" is not an instruction Replied, post #12 · Practice › Reconstitution · 28 Nov 2025 · 14 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Reconciling a supplier certificate with an independent result Replied, post #13 · Sourcing › Vendor reports · 24 Oct 2025 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Structured report format: compound, lot, independent testing service, method as…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #39 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #22 · Documentation › Doc review · 17 Oct 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
-
Follow-up: Why appetite effects are mostly central Replied, post #25 · Pharmacology › Receptor biology · 25 Aug 2025 · 0 likes post #24 is right about the mechanism and I think understates the practical bit. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
-
A request that was declined, and the reasoning — a second dataset Replied, post #34 · Documentation › Wiki requests · 9 Aug 2025 · 8 likes Worth separating two things that post #30 runs together. Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion…
-
A field-by-field walk through a certificate of analysis Replied, post #133 · Analytics › COA interpretation · 18 Jul 2025 · 27 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #6 · Evidence › Trials · 31 May 2025 · 30 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #71 · Sourcing › Independent verification · 9 May 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Follow-up: What other technical communities get right that we do not Replied, post #82 · Lounge › Off topic · 29 Apr 2025 · 6 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Requesting a page: what makes a good request Replied, post #29 · Documentation › Wiki requests · 20 Mar 2025 · 24 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #6 · Evidence › Journal club · 21 Feb 2025 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #14 · Practice › Reconstitution · 14 Nov 2024 · 2 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…